Equities analysts predict that Global Medical REIT Inc (NYSE:GMRE) will report sales of $16.74 million for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Global Medical REIT’s earnings. The lowest sales estimate is $15.93 million and the highest is $17.15 million. Global Medical REIT posted sales of $13.25 million in the same quarter last year, which suggests a positive year-over-year growth rate of 26.3%. The business is expected to announce its next earnings report on Tuesday, August 6th.

On average, analysts expect that Global Medical REIT will report full year sales of $67.86 million for the current fiscal year, with estimates ranging from $63.21 million to $71.18 million. For the next fiscal year, analysts expect that the business will post sales of $81.19 million, with estimates ranging from $65.18 million to $94.27 million. Zacks’ sales calculations are a mean average based on a survey of research firms that follow Global Medical REIT.

Global Medical REIT (NYSE:GMRE) last released its earnings results on Wednesday, May 8th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.18). Global Medical REIT had a return on equity of 5.52% and a net margin of 21.38%. The company had revenue of $15.20 million for the quarter, compared to the consensus estimate of $15.32 million.

Several analysts recently issued reports on GMRE shares. TheStreet upgraded Global Medical REIT from a “c+” rating to a “b” rating in a report on Thursday, May 9th. Stifel Nicolaus started coverage on Global Medical REIT in a report on Monday, April 15th. They set a “buy” rating and a $11.00 target price on the stock. Zacks Investment Research lowered Global Medical REIT from a “buy” rating to a “hold” rating in a report on Tuesday, March 12th. Boenning Scattergood reissued a “buy” rating on shares of Global Medical REIT in a research report on Thursday, March 7th. Finally, B. Riley set a $11.00 price target on Global Medical REIT and gave the stock a “buy” rating in a research report on Friday, March 8th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the stock. Global Medical REIT presently has a consensus rating of “Buy” and an average price target of $10.67.

GMRE traded down $0.27 on Tuesday, hitting $10.73. 356,400 shares of the company were exchanged, compared to its average volume of 314,895. Global Medical REIT has a 12 month low of $8.10 and a 12 month high of $11.51. The company has a market cap of $379.03 million, a P/E ratio of 13.76, a PEG ratio of 1.63 and a beta of 0.46. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.76. The company has a fifty day moving average price of $10.79.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 11th. Shareholders of record on Wednesday, June 26th will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 7.46%. The ex-dividend date is Tuesday, June 25th. Global Medical REIT’s dividend payout ratio (DPR) is presently 102.56%.

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. BlackRock Inc. grew its position in shares of Global Medical REIT by 3.9% in the fourth quarter. BlackRock Inc. now owns 1,059,753 shares of the company’s stock valued at $9,422,000 after purchasing an additional 39,560 shares during the last quarter. Vanguard Group Inc. grew its position in shares of Global Medical REIT by 0.9% in the third quarter. Vanguard Group Inc. now owns 899,741 shares of the company’s stock valued at $8,475,000 after purchasing an additional 7,614 shares during the last quarter. Marshall Wace LLP acquired a new position in shares of Global Medical REIT in the first quarter valued at approximately $6,569,000. State of New Jersey Common Pension Fund D boosted its stake in shares of Global Medical REIT by 11.8% in the first quarter. State of New Jersey Common Pension Fund D now owns 657,143 shares of the company’s stock valued at $6,453,000 after buying an additional 69,143 shares during the period. Finally, Psagot Investment House Ltd. bought a new stake in shares of Global Medical REIT in the first quarter valued at approximately $6,085,000. 51.96% of the stock is currently owned by hedge funds and other institutional investors.

About Global Medical REIT

Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Further Reading: What are Bollinger Bands?

Get a free copy of the Zacks research report on Global Medical REIT (GMRE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.